Pronounced racial HIV disparities persist in the US, with some signs of slow improvement
Large numbers now on Descovy PrEP in the United States
By 2030, a quarter of people taking HIV treatment in the US will be over 65 and most will have multiple health concerns
Better access to PrEP in the UK, especially through NHS services
South Africans continued to receive ART during COVID-19 lockdown, but HIV testing and starting ART were impeded
Baltic neighbour states far apart on HIV prevention
New podcast series: Tell Me About It
Where next for HIV vaccines and antibody therapies?
African studies explore reasons to start, stick with or stop PrEP
